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Background
Delayed Enhanced MRI (DEMRI) with gadolinium (Gd)
is used as gold standard for diagnosis of myocardial
infarction. However, the non-specific property of Gd
overestimates the infarct size. Conversely, manganese
(Mn2+) enters only the live, active cardiomyocytes via
L-type Ca2+ channels. From our earlier work in animal
MI models, manganese-enhanced MRI (MEMRI) has
demonstrated its utility in identifying the viable, non-
viable, and injured myocardium. We performed the
“first in human” dual-contrast MEMRI-DEMRI to assess
the efficacy of MEMRI-DEMRI to identify the peri-
infarct region (PIR) in patients with severe ischemic
cardiomyopathy (ICM).
Methods
5 ICM patients (Class I-III CHF) have been enrolled
(5 male, mean age 60 ± 7 years). Cardiac MRI was per-
formed using a 3.0T MRI scanner (Signa 3T HDx, GE
HealthCare, USA) with an 8 channel cardiac coil (3.0T
HD Cardiac Array, GE HealthCare, USA). LV functional
images and DEMRI were acquired on the first day of
this study, and MEMRI was acquired on the following
week. (1) LV function: SSFP, flip angle (FA) 45, slice
thickness (ST) 8.0 mm, matrix 224 × 224, FOV 35.0 cm;
(2) DEMRI: FGRE-IR, TR 6.0, TE 2.8, TI 200-300, FA
15, ST 8.0 mm, matrix 224 × 192, FOV 35.0 cm, 0.2
mmol/kg Gd (Magnevist, Bayer HealthCare, Germany);
and (3) MEMRI: FGRE-IR, TR 6.0, TE 2.8, TI 600-700,
FA 15, ST 8.0 mm, matrix 224 × 192, FOV 35.0 cm, 1
mmol/kg SeeMore (Eagle Vision Pharmaceutical, USA)
were performed. The infarct volumes were determined
as 3 standard deviations (SDs) above mean on DEMRI
and 2 SDs below mean on MEMRI using a Cardiac MRI
Software (CMR42, Circle Cardiovascular Imaging Inc.,
Canada).
Results
The average LVEF was 35 ± 4%. The % enhanced
DEMRI infarct volume (34 ± 11%*) was significantly
(*p < 0.05) higher than the % defect MEMRI infarct
volume (14 ± 3%). The PIR was calculated as the differ-
ence between DEMRI and MERMRI. The mean % PIR
per total LV and the mean % PIR per DEMRI enhance-
ment were 20 ± 12% (Figure 1) and 56 ± 16% (Figure 2),
respectively.
Conclusions
The non-viable myocardium volume, appearing as
MEMRI defect, was significantly smaller than the DEMRI
enhancement. The discrepancy between DEMRI and
MEMRI may represent the PIR or “area-at-risk”. There-
fore, our results suggest that the dual MEMRI-DEMRI
contrast may clearly delineate the PIR by integrating the
biology of viable myocardium and anatomy of non-viable
myocardium. Further studies on the ability of this dual
contrast approach to delineate the area-at-risk and to
predict clinical outcomes from revascularization are
necessary.
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Figure 1 The percentage Peri-Infarct Region (PIR) per total LV volume.
Figure 2 The percentage Peri-Infarct Region (PIR) per DEMRI enhanced volume.
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